European Journal of Clinical Microbiology

, Volume 6, Issue 2, pp 190–190 | Cite as

Activity of LY146032 and vancomycin against coagulase-negative staphylococci

  • D. E. Low
  • R. Poon
New Antimicrobial Agents


Internal Medicine Vancomycin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Eliopoulos, G. M., Thauvin, C., Gerson, B., Moellering, R. C.: In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrobial Agents and Chemotherapy 1985, 27: 357–362.PubMedGoogle Scholar
  2. 2.
    Archer G. L.: Antibiotic resistance in coagulase-negative Staphylococci. In: Mardh, P. A., Schleifer, K. H. (ed.): Coagulase-negative Staphylococci. Almqvist and Wilksell Stockholm, 1986, p. 93–101.Google Scholar
  3. 3.
    National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M7-A. Villanova, PA, 1985.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1987

Authors and Affiliations

  • D. E. Low
    • 1
  • R. Poon
    • 1
  1. 1.Department of MicrobiologyMount Sinai HospitalTorontoCanada

Personalised recommendations